Skip to content
Screener

Revvity RVTY Investing Cash Flow

Investing Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$164M+157%
Danaher logo
DanaherDHR
-$10.15B-3,833%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$90M-13.6%
WAT
Waters CorporationWAT
$2M+103%
Agilent Technologies logo
Agilent TechnologiesA
-$77M+32.5%
Illumina logo
IlluminaILMN
-$121M-147%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$12.83B+28.7%
Enterprise value$15.91B+28.6%
P/E53.5×+18.6×
P/S4.4×+0.9×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Revvity’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000031791-26-000019
Line itemThree Months Ended / April 5,2026Three Months Ended / March 30,2025
Cash paid for acquisitions, net of cash acquired(67,280)
Net cash used in investing activities of continuing operations(78,272)(15,753)
Net cash provided by investing activities of discontinued operations9,375
Net cash used in investing activities(78,272)(6,378)
Financing activities:
Payments of debt financing issuance costs(2,402)
Payments of other credit facilities(50)
Payments for acquisition-related contingent consideration(1,817)

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's investing cash flow?
Revvity (RVTY) reported investing cash flow of -$78.27M in Q1 2026.
How has Revvity's investing cash flow changed year-over-year?
Revvity's investing cash flow decreased by 1127.2% year-over-year, from -$6.38M to -$78.27M.
What is the long-term trend for Revvity's investing cash flow?
Over 3 years (2021 to 2025), Revvity's investing cash flow has grown at a -83.8% compound annual growth rate (CAGR), from -$4.11B to -$17.35M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Revvity's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude